Basilea Pharmaceutica Ltd. is headquartered in Basel, Switzerland. The company focuses on providing innovative pharmaceutical products in the therapeutic areas of bacterial infections, fungal infections and oncology, targeting the medical challenge of rising resistance and non response to current treatment options.
Quote | Basilea Pharm Ag Akt Shs (OTCMKTS:BPMUF)
Last: | $47 |
---|---|
Change Percent: | 0.0% |
Open: | $47 |
Close: | $47 |
High: | $47 |
Low: | $47 |
Volume: | 11 |
Last Trade Date Time: | 07/17/2024 03:00:00 am |
News | Basilea Pharm Ag Akt Shs (OTCMKTS:BPMUF)
China Yuchai International Limited (CYD) is expected to report for Q1 2024 Avid Bioservices Inc. (CDMO) is expected to report $0.03 for Q4 2024 Derwent London Plc (DWVYF) is expected to report for Q1 2024 Fresnillo Plc (FNLPF) is expected to report for Q1 2024 Basilea Pharmaceutic...
GreenTree Hospitality Group Ltd. American depositary shares each representing one Class A (GHG) is expected to report for Q1 2024 Air T Inc. (AIRT) is expected to report for Q4 2024 Alimentation-Couche Tard Inc. - Class A (Multiple Voting) (ANCTF) is expected to report for Q4 2024 Man...
Message Board Posts | Basilea Pharm Ag Akt Shs (OTCMKTS:BPMUF)
Subject | By | Source | When |
---|---|---|---|
Stock_Tracker: Latest Basilea Pharmaceutic (BPMUF) Headlines Astellas Secures Exclusive Rights to Co | Stock_Tracker | investorshangout | 03/09/2014 8:12:57 AM |
chartguy89: BPMUF 140.00 Stock Charts $BPMUF 1 Month Chart | chartguy89 | investorshangout | 03/06/2014 9:44:19 AM |
Stock_Tracker: BPMUF Recent News Astellas Secures Exclusive Rights to Commercialize Isavuconazole in | Stock_Tracker | investorshangout | 03/03/2014 8:23:31 AM |
chartguy89: BPMUF Stock Charts Monday, February 24, 2014 at 12:34:42 AM $BPMUF Last: -2.55 | chartguy89 | investorshangout | 02/24/2014 5:34:54 AM |
News, Short Squeeze, Breakout and More Instantly...
Basilea Pharm Ag Akt Shs Company Name:
BPMUF Stock Symbol:
OTCMKTS Market:
China Yuchai International Limited (CYD) is expected to report for Q1 2024 Avid Bioservices Inc. (CDMO) is expected to report $0.03 for Q4 2024 Derwent London Plc (DWVYF) is expected to report for Q1 2024 Fresnillo Plc (FNLPF) is expected to report for Q1 2024 Basilea Pharmaceutic...
GreenTree Hospitality Group Ltd. American depositary shares each representing one Class A (GHG) is expected to report for Q1 2024 Air T Inc. (AIRT) is expected to report for Q4 2024 Alimentation-Couche Tard Inc. - Class A (Multiple Voting) (ANCTF) is expected to report for Q4 2024 Man...
Allschwil, Switzerland, June 20, 2024 Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial and fungal infections, announced today that it has entered into an asset purchase agreement w...